Health News Releases

  • Today April 22
April 19, 2022 16:30
Takeda Announces Approval of Nuvaxovid® COVID-19 Vaccine for Primary and Booster Immunization in Japan
Takeda (TSE:4502/NYSE:TAK) today announced that it has received manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare (MHLW) for Nuvaxovid® Intramuscular Injection
April 19, 2022 15:00
Surging Hospitalization Rates For Numerous Chronic And Infectious Ailments Are Driving Demand For Hospital Supplies Market: Fact.MR
According to the latest Fact.MR analysis, the global hospital supplies market is predicted to grow at a CAGR of over 3%, reaching US$ 23 Bn by the end of the 2021-2031 forecast period, concludes Fact.
April 15, 2022 14:30
Kaneka Launches New PCR Test Kit for Identifying the COVID-19 Omicron (BA.1) and “Stealth” Omicron (BA.2) Variants
On March 31, Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka) released KANEKA RT-PCR Kit “SARS-CoV-2 (Omicron/Delta) ver.2”, a real-time PCR test kit capable of simultaneo
April 15, 2022 14:15
Advanced Clinical Continues Global Expansion Into Europe With New Office in Switzerland
Advanced Clinical, a clinical development and strategic resourcing organization, is pleased to announce its continued expansion into Europe with the opening of a new office in Zug, Switzerland. “We
April 15, 2022 09:30
Advancement In Oxygen Concentrators Industry Drives Revenue Share Upsurge By 2031... Projected To Top USD 5 Bn: Fact.MR's Latest Survey
As per a new report published by Fact.MR - Market research and competitive intelligence provider, the market for medical oxygen systems is anticipated to top US$ 5 Bn by 2031 and expand at a CAGR of 7
April 14, 2022 10:30
Takeda Announces Completion of Acquisition of Own Shares
Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today provided an update on the status and announced the completion of the acquisition of its own shares, which has been carried
April 13, 2022 09:30
Takeda’s TAKHZYRO® (lanadelumab) Open Label Phase 3 Study Met Its Objectives in Children Ages 2 to <12 Years of Age With Hereditary Angioedema (HAE)
Takeda (TSE:4502/NYSE:TAK) today announced that the Phase 3 SHP643-301 study (NCT04070326) evaluating the safety profile and pharmacokinetics (PK) of TAKHZYRO® (lanadelumab) in patients 2 to
April 12, 2022 18:00
Top 10 Finalist Nurses Announced for Inaugural Aster Guardians Global Nursing Award
Aster Guardians Global Nursing Award has just announced its top 10 finalists hailing from across the world. These nurses have been selected from over 24,000 nurses who applied from over 184 countries,
April 12, 2022 10:45
DentalMonitoring, the Industry-leader in AI-powered Dental Software, Is Creating a New Business Unit, the DM Lab, as The Company Targets Continued Growth and Expansion
The purpose of the DM Lab will be to explore, test and validate business opportunities across the broad dental market, as DentalMonitoring expands its technological leadership as well as its geographi
April 12, 2022 09:15
The GXP Engaged Auditing Services Group of Companies Announces the Opening of Its UK Subsidiary, GXP Engaged Auditing Services UK Ltd.
As well as extending the reach of our comprehensive contract quality management and auditing services for our clients in the pharmaceutical, biotechnology, medical devices, nutrition and healthcare in
April 11, 2022 11:00
Rhizen Pharmaceuticals AG Presents Data on Its Differentiated PARP and DHODH Inhibitor Programs at AACR 2022
Rhizen Pharmaceuticals AG (Rhizen), a Switzerland-based privately held, clinical-stage oncology & inflammation-focussed biopharmaceutical company, announced the release of data on its differentiated n
April 08, 2022 14:40
LevitasBio Announces the LeviCell EOS System: A New Era in Sample Processing and Characterization
LevitasBio, Inc. today unveiled the LeviCell™ EOS System, their next generation solution for cell separation and enrichment, featuring higher throughput and simultaneous targeted selection of viable c
April 07, 2022 16:30
Alvotech and STADA Pave Way to Launching HUKYNDRA®(AVT02), a Citrate-free, High-concentration Biosimilar to Humira® by Resolving European Patent Dispute With AbbVie
Alvotech Holdings S.A. (“Alvotech”), a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, has today announced the resolu
April 07, 2022 09:55
BostonGene Announces $150 Million Series B Funding at a Multi-Billion Dollar Valuation, Propelling the Company to Unicorn Status
BostonGene today announced the completion of the $150 million Series B funding. NEC Corporation (NEC; TSE: 6701) led the financing with participation from Impact Investment Capital and Japan Industria
April 06, 2022 15:50
Takeda and the New York Academy of Sciences Announce 2022 Innovators in Science Award Winners
Takeda (TSE:4502/NYSE:TAK) and the New York Academy of Sciences today announced the winners of the fourth Innovators in Science Award for their excellence in, and commitment to, innovative science tha
April 06, 2022 15:00
Medline to Acquire ASID BONZ
Medline International B.V., a leading manufacturer and distributor of healthcare supplies in Europe, and Medi-Globe Group, headquartered in Germany, announced today that Medline has entered into a def
April 06, 2022 10:30
Saladax Biomedical, Inc. Acquires Intellectual Property Portfolio for Antipsychotic Drug Tests
Saladax Biomedical, Inc. (Saladax) is pleased to announce that it has acquired a patent portfolio for antipsychotic drug testing from Janssen Pharmaceutica NV. This intellectual property (IP) portfoli
April 06, 2022 09:45
South African Teaching Hospital Achieves CRE Superbug Decrease Following Novel Environmental Hygiene Intervention
Wits University Donald Gordon Medical Centre announced novel study results indicating for the first time that Ultraviolet (UV) room decontamination technology paired with manual cleaning protocols dec
World’s-first tonsil epithelial organoids model for SARS-CoV-2 infection.
April 06, 2022 08:40
Korean Research Team Establishes World’s First Tonsil Epithelial Organoids Model for SARS-CoV-2 Infection
The research team led by Professor Jongman Yoo (Cha University and CEO of ORGANOIDSCIENCES) along with Professor Young-Chang Lim (Konkuk University) and Dr. Meehyein Kim (Korea Research Institute of C
April 05, 2022 17:30
Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
In 2021, Boehringer Ingelheim again stepped up its annual investments in R&D to a new high in its 137-year history. The company spent 4.1 billion EUR on R&D (2020: 3.7 billion EUR), up 11.7%. R&D inve
April 05, 2022 14:00
Patient Safety Movement Foundation Announces Dates and Speaker Line-up for 8th Annual World Patient Safety, Science & Technology Summit
The Patient Safety Movement Foundation (PSMF) will host the 8th annual World Patient Safety, Science and Technology Summit (WPSSTS) virtually April 29 and April 30, 2022. The event is co-convened by t
April 04, 2022 14:10
DIAMOND trial: Veltassa® enables patients to achieve long-term potassium control and optimized RAASi therapy
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma today announced full results from its phase-IIIb DIAMOND trial showing that Veltassa® allowed patients to achieve long-te
April 04, 2022 14:00
Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting
Takeda (TOKYO:4502/NYSE:TAK) today announced that its Board of Directors will propose two new candidates for independent external directors at the 146th Ordinary Meeting of Shareholders on June 29, 20
April 04, 2022 09:30
Merck Shares Advances in MS Portfolio with Key Efficacy and Safety Data at AAN 2022
DARMSTADT, Germany--(BUSINESS WIRE)-- Merck, a leading science and technology company, today announced 13 abstracts from the Company’s multiple sclerosis (MS) portfolio will be presented at the 2022 A
April 01, 2022 11:15
Labcorp Renews Strategic Partnership with Medidata to Provide Suite of Clinical Trial Technologies and Services
Medidata, a Dassault Systèmes company, announced that Labcorp, a leading global life sciences company, has selected Medidata's technology platform to extend their 14-year partnership, the foundation o
25 per page50 per page75 per page100 per page